2022 MIPS Measure #309: Cervical Cancer Screening

Description

Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:

  • Women age 21-64 who had cervical cytology performed within the last 3 years
  • Women age 30-64 who had cervical human papillomavirus (HPV) testing performed within the last 5 years

Initial Population

Women 23-64 years of age with a visit during the measurement period

Denominator

Equals Initial Population

Denominator Exclusions

  • Women who had a hysterectomy with no residual cervix or a congenital absence of cervix.
  • Exclude patients who are in hospice care for any part of the measurement period.
  • Exclude patients receiving palliative care during the measurement period.

Numerator

Women with one or more screenings for cervical cancer. Appropriate screenings are defined by any one of the following criteria:

  • Cervical cytology performed during the measurement period or the two years prior to the measurement period for women who are at least 21 years old at the time of the test
  • Cervical human papillomavirus (HPV) testing performed during the measurement period or the four years prior to the measurement period for women who are 30 years or older at the time of the test

Numerator Exclusions

Not Applicable

Denominator Exceptions

None


Tags

CMS-Family-Medicine-2022, CMS-Internal-Medicine-2022, CMS-Obstetrics-Gynecology-2022, Internal Medicine, Obstetrics/Gynecology, Quality-2022